These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20501799)

  • 1. Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.
    Zhong B; Sallman DA; Gilvary DL; Pernazza D; Sahakian E; Fritz D; Cheng JQ; Trougakos I; Wei S; Djeu JY
    Mol Cancer Ther; 2010 Jun; 9(6):1831-41. PubMed ID: 20501799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusterin mediates TRAIL resistance in prostate tumor cells.
    Sallman DA; Chen X; Zhong B; Gilvary DL; Zhou J; Wei S; Djeu JY
    Mol Cancer Ther; 2007 Nov; 6(11):2938-47. PubMed ID: 18025278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted clusterin gene silencing enhances chemosensitivity of a549 cells to cisplatin through AKT and ERK1/2 pathways in vitro.
    Zhang B; Zhang K; Liu Z; Hao F; Wang M; Li X; Yin Z; Liang H
    Cell Physiol Biochem; 2014; 33(4):1162-75. PubMed ID: 24751980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells.
    Zhou J; Chen X; Gilvary DL; Tejera MM; Eksioglu EA; Wei S; Djeu JY
    Sci Rep; 2015 Oct; 5():15085. PubMed ID: 26469759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma.
    Xiu P; Dong X; Dong X; Xu Z; Zhu H; Liu F; Wei Z; Zhai B; Kanwar JR; Jiang H; Li J; Sun X
    Cancer Sci; 2013 Mar; 104(3):375-82. PubMed ID: 23279642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyceryl trinitrate‑induced cytotoxicity of docetaxel‑resistant prostatic cancer cells is associated with differential regulation of clusterin.
    Bouaouiche S; Magadoux L; Dondaine L; Reveneau S; Isambert N; Bettaieb A; Jeannin JF; Laurens V; Plenchette S
    Int J Oncol; 2019 Apr; 54(4):1446-1456. PubMed ID: 30720069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.
    Bertacchini J; Mediani L; Beretti F; Guida M; Ghalali A; Brugnoli F; Bertagnolo V; Petricoin E; Poti F; Arioli J; Anselmi L; Bari A; McCubrey J; Martelli AM; Cocco L; Capitani S; Marmiroli S
    J Cell Physiol; 2019 Jul; 234(7):11188-11199. PubMed ID: 30565691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression.
    Wang Y; Wang X; Zhao H; Liang B; Du Q
    J Chemother; 2012 Dec; 24(6):348-57. PubMed ID: 23174100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells.
    Patterson SG; Wei S; Chen X; Sallman DA; Gilvary DL; Zhong B; Pow-Sang J; Yeatman T; Djeu JY
    Oncogene; 2006 Oct; 25(45):6113-22. PubMed ID: 16652143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-1 activates the P13K/AKT signaling pathway via upregulation of secretory clusterin.
    Ma X; Bai Y
    Mol Med Rep; 2012 Dec; 6(6):1433-7. PubMed ID: 23027041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy.
    Sowery RD; Hadaschik BA; So AI; Zoubeidi A; Fazli L; Hurtado-Coll A; Gleave ME
    BJU Int; 2008 Aug; 102(3):389-97. PubMed ID: 18336596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory clusterin promotes oral cancer cell survival via inhibiting apoptosis by activation of autophagy in AMPK/mTOR/ULK1 dependent pathway.
    Naik PP; Mukhopadhyay S; Praharaj PP; Bhol CS; Panigrahi DP; Mahapatra KK; Patra S; Saha S; Panda AK; Panda K; Paul S; Aich P; Patra SK; Bhutia SK
    Life Sci; 2021 Jan; 264():118722. PubMed ID: 33160989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clusterin and chemoresistance.
    Djeu JY; Wei S
    Adv Cancer Res; 2009; 105():77-92. PubMed ID: 19879424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-195 regulates docetaxel resistance by targeting clusterin in prostate cancer.
    Ma X; Zou L; Li X; Chen Z; Lin Q; Wu X
    Biomed Pharmacother; 2018 Mar; 99():445-450. PubMed ID: 29665645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic downregulation of RUNX3 by DNA methylation induces docetaxel chemoresistance in human lung adenocarcinoma cells by activation of the AKT pathway.
    Zheng Y; Wang R; Song HZ; Pan BZ; Zhang YW; Chen LB
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2369-78. PubMed ID: 23892093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. siRNA-directed clusterin silencing promotes cisplatin antitumor activity in human non-small cell lung cancer xenografts in immunodeficient mice.
    Zhang B; Liu ZM; Hao FG; Wang M
    Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1595-601. PubMed ID: 24943969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p.
    Mu L; Yang F; Guo D; Li P; Zhang M
    Bioengineered; 2020 Dec; 11(1):472-483. PubMed ID: 32250192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clusterin, a Novel DEC1 Target, Modulates DNA Damage-Mediated Cell Death.
    Ming X; Bao C; Hong T; Yang Y; Chen X; Jung YS; Qian Y
    Mol Cancer Res; 2018 Nov; 16(11):1641-1651. PubMed ID: 30002194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma.
    Cui SY; Huang JY; Chen YT; Song HZ; Feng B; Huang GC; Wang R; Chen LB; De W
    Mol Cancer Res; 2013 Jul; 11(7):699-713. PubMed ID: 23562878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanism Mediating Cytotoxic Activity of Cabazitaxel in Docetaxel-resistant Human Prostate Cancer Cells.
    Watanabe H; Kawakami A; Sato R; Watanabe K; Matsushita Y; Miyake H
    Anticancer Res; 2021 Aug; 41(8):3753-3758. PubMed ID: 34281834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.